(0.81%) 5 169.30 points
(0.30%) 38 791 points
(0.94%) 16 308 points
(0.74%) $78.69
(2.57%) $2.20
(1.11%) $2 334.20
(3.75%) $27.69
(0.07%) $965.95
(-0.08%) $0.928
(-0.48%) $10.82
(-0.17%) $0.796
(-0.13%) $91.33
1.75% ¥ 4 821.00
Live Chart Being Loaded With Signals
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business...
Stats | |
---|---|
Tagesvolumen | 308 700 |
Durchschnittsvolumen | 292 518 |
Marktkapitalisierung | 300.54B |
EPS | ¥0 ( 2024-02-08 ) |
Nächstes Ertragsdatum | ( ¥83.23 ) 2024-05-13 |
Last Dividend | ¥36.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 14.25 |
ATR14 | ¥2.70 (0.06%) |
Volumen Korrelation
Suzuken Co., Ltd. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Suzuken Co., Ltd. Korrelation - Währung/Rohstoff
Suzuken Co., Ltd. Finanzdaten
Annual | 2022 |
Umsatz: | ¥2 314.83B |
Bruttogewinn: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
Umsatz: | ¥2 314.83B |
Bruttogewinn: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
Umsatz: | ¥2 232.77B |
Bruttogewinn: | ¥160.99B (7.21 %) |
EPS: | ¥163.19 |
FY | 2021 |
Umsatz: | ¥2 128.48B |
Bruttogewinn: | ¥157.84B (7.42 %) |
EPS: | ¥88.52 |
Financial Reports:
No articles found.
Suzuken Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥36.00 (N/A) |
¥0 (N/A) |
¥36.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥9.09 | 2001-03-27 |
Last Dividend | ¥36.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥939.27 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.84 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 2.58 | |
Div. Directional Score | 4.59 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8050.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7294.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6540.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
5852.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4553.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3788.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3050.T | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
1930.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
9474.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8383.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0117 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0212 | 1.200 | 9.29 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0664 | 1.500 | -0.373 | -0.560 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.186 | 0.800 | 9.07 | 7.26 | [1 - 3] |
quickRatioTTM | 0.954 | 0.800 | 9.10 | 7.28 | [0.8 - 2.5] |
cashRatioTTM | 0.206 | 1.500 | 9.97 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 807.19 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0775 | 1.000 | -2.04 | -2.04 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0146 | 1.000 | -1.707 | -1.707 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.818 | 0.800 | 1.213 | 0.970 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.11 | 1.000 | 8.68 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0664 | 2.50 | -0.240 | -0.560 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.659 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.66 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00727 | 1.000 | -2.32 | 0 | [0.1 - 0.5] |
Total Score | 2.58 |
Suzuken Co., Ltd.
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.